President of DePuy Orthopaedics resigns in wake of hip implant recall

The Wall Street Journal reports that David Floyd, president of DePuy Orthopaedics division of Johnson & Johnson, announced that he is resigning his position after a transition period. A successor has not yet been named.

Floyd has been in a pressure cooker of a job since Depuy recalled their ASR XL Acetabular and Hip Resurfacing Systems in August of 2010 because of a high rate of failures. The hip implants were recalled after studies showed that in only five years, 12 to 13 percent of patients required a repeat or revision surgery.

According to the WSJ, DePuy has placed $280 million in reserves in the fourth quarter to “cover reasonable and customary testing and treatment for people with the implants.”

DePuy may be in the hot seat for years to come as the hip implants have been linked to a rare condition called metallosis which is caused by the release of metal ions of cobalt and chromium in the blood suit.

Already, DePuy is facing more than 500 product liability lawsuits from people who have suffered serious personal injuries and financial losses because of the faulty implants.

This information is provided by Washington Injury Attorney blog, a service of The Farber Law Group. We represent people who have suffered medical complications due to the faulty DePuy hip implant systems. With our help, you may recover compensation for your damages including pain and suffering and for loss of wages.

Related Posts:

Johnson & Johnson issues recall of hip replacement implants

Nearly half of DePuy ASR hip implant patients in Ireland may need 2nd surgery

Women risk higher DePuy hip replacement redos then men

Contact The Farber Law Group at 1-800-244-9087 or attorney@hgfarber.com to schedule a free and confidential case evaluation. We have offices in Seattle and Bellevue to assist you.